Cart
sales@molnova.com
Nimustine Hydrochloride
CAS No. 55661-38-6
Nimustine Hydrochloride( Nidran hydrochloride )
Catalog No. M19815 CAS No. 55661-38-6
Nimustine has been used in trials studying the treatment of Glioblastoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 186 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNimustine Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimustine has been used in trials studying the treatment of Glioblastoma.
-
DescriptionNimustine has been used in trials studying the treatment of Glioblastoma.
-
In Vitro——
-
In Vivo——
-
SynonymsNidran hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
IndicationGlioblastoma
Chemical Information
-
CAS Number55661-38-6
-
Formula Weight309.15
-
Molecular FormulaC9H14Cl2N6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:55 mg/mL(177.9 mM)
-
SMILESCl.Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1
-
Chemical NameUrea N'-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(2-chloroethyl)-N-nitroso- monohydrochloride (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matsumoto T. et al.: J. Eur. Acad. Dermatol. Venereol. 27 1514 (2013).
molnova catalog
related products
-
Pentachloropseudilin
Pentachloropseudilin (PClP) is a reversible variant 1 myosin inhibitor with antimicrobial activity that inhibits Myo1s and class 5 myosins.
-
Ivermectin B1a
Ivermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.
-
Menaquinone-7
Menaquinone-7 is a vitamin K2 analog, is originally discovered as the anti-hemorrhagic factors. Menaquinone-7 (Vitamin K2-7) is identified as the most bioactive cofactor for the carboxylation reaction of Gla-proteins.
